• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Barksdale Resources Corp
Clarity Metals Corp
Profound Medical Corp. - common stock
Resaas Services Inc
XTL Biopharmaceuticals Ltd. - American Depositary Shares
Edit Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

RxSight, Inc. - Common Stock (NQ:RXST)

4.690 UNCHANGED
Delayed Quote Updated: 4:00 PM EDT, Oct 19, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 4.690
Bid (Size) 4.400 (1,000)
Ask (Size) 5.000 (200)
Prev. Close 4.690
Today's Range 4.690 - 4.690
52wk Range 4.400 - 13.22
Shares Outstanding 33,981,877
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
RxSight Appoints Eye Care Industry Leaders to Drive Commercial Transformation
October 19, 2026
From RxSight, Inc.
Via GlobeNewswire
News headline image
RxSight, Inc. to Participate in the Wells Fargo Healthcare Conference
August 26, 2026
From RxSight, Inc.
Via GlobeNewswire

Performance

52-Week Range 64.5% below 52-week high
4.690
4.4052W Low 13.2252W High
1 Week 2.9% below 1-week high
4.401W Low 4.831W High

RxSight, Inc. - Common Stock (RXST) traded between $4.40 and $13.22 over the past 52 weeks and last traded at $4.69, 64.5% below its 52-week high. Over the past week it ranged between $4.40 and $4.83.

Past 12 Months
+3.5%
-8.8%
-16.4%
-37.0%
-54.8%
-45.0%
1W +$0.16
1M -$0.45
3M -$0.92
6M -$2.75
YTD -$5.69
1Y -$3.84

RXST was -45.0% over the past year, -37.0% over six months, -54.8% year to date, +3.5% in the last week.

12 Months vs Market
RXST
-45.0%
DIA
+11.1%
SPY
+14.2%
QQQ
+17.5%
IWM
+9.3%

Over the past 12 months RXST returned -45.0% versus DIA (Dow) +11.1%, SPY (S&P 500) +14.2%, QQQ (Nasdaq 100) +17.5% and IWM (Russell 2000) +9.3%.

Volume & Liquidity
1W
783.5K
1M
773.1K
3M
835.7K
6M
942.0K
YTD
936.4K
1Y
902.3K

RXST's 3-month average daily volume is 835.7K.

More News

Read More
News headline image
RxSight (RXST) Q2 2026 Earnings Call Transcript ↗
August 12, 2026
Via The Motley Fool
Topics Earnings
News headline image
RxSight Q2 Earnings Call Highlights ↗
August 06, 2026
Via MarketBeat
Topics Earnings
RxSight (NASDAQ:RXST) Slips After Q2 Revenue Matches, Loss Narrows ↗
August 05, 2026
Via Chartmill
RxSight (NASDAQ:RXST) Q1 2026 Results: Revenue Beats but Loss Widens Amid Cautious Market Reaction ↗
May 06, 2026
Via Chartmill
News headline image
RxSight, Inc. Reports Second Quarter 2026 Results and Provides Update on 2026 Outlook
August 05, 2026
From RxSight, Inc.
Via GlobeNewswire
News headline image
RxSight Reports Inducement Grants as Permitted by the Nasdaq Listing Rules
July 26, 2026
From RxSight, Inc.
Via GlobeNewswire
News headline image
RxSight Announces Appointments of Aziz Mottiwala as Chief Executive Officer and Ron Kurtz, M.D. as Chief Medical Officer
July 15, 2026
From RxSight, Inc.
Via GlobeNewswire
News headline image
RxSight Q2 Sales Sink 20% as Alcon Deal Bolsters 2026 Outlook ↗
July 10, 2026
Via MarketBeat
RXSIGHT INC (NASDAQ:RXST) Reports Q4 Beat but Cautious 2026 Outlook Weighs on Shares ↗
February 25, 2026
Via Chartmill
News headline image
Glancy Prongay Wolke & Rotter LLP Announces Investigation of RxSight, Inc. (RXST) on Behalf of Investors
July 10, 2026
From Glancy Prongay Wolke & Rotter LLP
Via Business Wire
News headline image
Law Offices of Howard G. Smith Announces Investigation of RxSight, Inc. (RXST) on Behalf of Investors
July 08, 2026
From Law Offices of Howard G. Smith
Via Business Wire
News headline image
The Law Offices of Frank R. Cruz Announces Investigation of RxSight, Inc. (RXST) on Behalf of Investors
July 07, 2026
From The Law Offices of Frank R. Cruz
Via Business Wire
News headline image
RxSight, Inc. Announces Preliminary Second Quarter Financial Results and Product Pipeline Updates Following Strategic Collaboration Agreement
July 06, 2026
From RxSight, Inc.
Via GlobeNewswire
News headline image
Alcon and RxSight Announce Collaboration to Develop Adjustable PCIOLs
July 06, 2026
From RxSight, Inc.
Via GlobeNewswire
News headline image
RxSight, Inc. to Present at the Stifel 2026 Virtual Ophthalmology Forum
May 19, 2026
From RxSight, Inc.
Via GlobeNewswire
News headline image
RxSight (RXST) Q1 2026 Earnings Transcript ↗
May 12, 2026
Via The Motley Fool
News headline image
RxSight, Inc. Reports First Quarter 2026 Results and Reiterates Full-Year Sales Outlook
May 06, 2026
From RxSight, Inc.
Via GlobeNewswire
News headline image
RxSight, Inc. to Present at the Bank of America Healthcare Conference
April 29, 2026
From RxSight, Inc.
Via GlobeNewswire
News headline image
RxSight, Inc. to Report First Quarter 2026 Financial Results on May 6
April 22, 2026
From RxSight, Inc.
Via GlobeNewswire
News headline image
RxSight, Inc. to Participate in the 25th Annual Needham Virtual Healthcare Conference
April 02, 2026
From RxSight, Inc.
Via GlobeNewswire
News headline image
RxSight (RXST) Q4 2025 Earnings Call Transcript ↗
February 25, 2026
Via The Motley Fool
Topics Earnings
News headline image
RXSight, Inc. Reports Fourth Quarter and 2025 Results; Issues 2026 Guidance
February 25, 2026
From RxSight, Inc.
Via GlobeNewswire
News headline image
RxSight, Inc. To Report Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026
February 11, 2026
From RxSight, Inc.
Via GlobeNewswire

Frequently Asked Questions

Is RxSight, Inc. - Common Stock publicly traded?
Yes, RxSight, Inc. - Common Stock is publicly traded.
What exchange does RxSight, Inc. - Common Stock trade on?
RxSight, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for RxSight, Inc. - Common Stock?
The ticker symbol for RxSight, Inc. - Common Stock is RXST on the Nasdaq Stock Market
What is the current price of RxSight, Inc. - Common Stock?
The current price of RxSight, Inc. - Common Stock is 4.690
When was RxSight, Inc. - Common Stock last traded?
The last trade of RxSight, Inc. - Common Stock was at 10/19/26 04:00 PM ET
What is the market capitalization of RxSight, Inc. - Common Stock?
The market capitalization of RxSight, Inc. - Common Stock is 159.38M
How many shares of RxSight, Inc. - Common Stock are outstanding?
RxSight, Inc. - Common Stock has 159M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap